Want to see PRVA full AI Analyst Report?
PRVA Stock Chart & Stats
$24.02
$0.26(1.28%)
At close: 4:00 PM EST
$24.02
$0.26(1.28%)
Day’s Range― - ―
52-Week Range$18.77 - $28.82
Previous CloseN/A
Volume48.95K
Average Volume (3M)1.23M
Market Cap
$3.39B
Enterprise Value$2.33K
Total Cash (Recent Filing)$419.52M
Total Debt (Recent Filing)$9.02M
Price to Earnings (P/E)152.1
Beta0.76
Next Earnings
Aug 06, 2026EPS Estimate
0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.17
Shares Outstanding126,012,375
10 Day Avg. Volume1,277,375
30 Day Avg. Volume1,228,438
Financial Highlights & Ratios
PEG Ratio2.14
Price to Book (P/B)3.93
Price to Sales (P/S)1.36
P/FCF Ratio17.86
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$30.60Price Target Upside27.39% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
EPS Forecast (FY)0.24
Revenue Forecast (FY)$2.42B
Bulls Say, Bears Say
Bulls Say
Provider & Attributed‑Lives ScaleRapid, durable network growth (5,535 providers, ~1.6M attributed lives) strengthens recurring management-fee economics and shared‑savings potential. Scale improves bargaining with payers, spreads fixed platform costs, and increases the addressable base for value‑based programs and cross‑sell opportunities.
Strong Balance Sheet & Low LeverageCash resources and minimal leverage provide lasting financial flexibility to fund acquisitions, invest in technology, and support working capital through value‑based payment timing. Low debt reduces refinancing risk and preserves capacity to execute M&A and sustain operations through reimbursement cycles.
Technology Leadership & M&A IntegrationA focused technology roadmap (CTO hire, generative AI deployments) combined with successful, early Evolent integration and an active pipeline supports durable margin expansion and care‑delivery efficiency. Tech and M&A scale can create structural competitive advantages in analytics and care management.
Bears Say
Thin Profit MarginsDespite return to positive net income, gross and operating margins are modest and TTM margins declined, leaving limited buffer against reimbursement pressure or cost inflation. Persistent thin margins increase sensitivity to contract mix, payer shifts, and integration expenses over the medium term.
Softening Cash Conversion MomentumWhile historical cash generation is positive, a ~15.7% TTM FCF decline and a negative operating cash coverage ratio signal recent working‑capital or timing stress. Weaker cash conversion reduces headroom to fund acquisitions and margin investments without relying on deal timing or external financing.
Payer/Policy & Shared‑Savings VariabilityStructural exposure to payer rules (e.g., CMS V28, Medicare Advantage shifts) and variability in shared‑savings recognition create durable revenue volatility. Management’s preference for upside‑only Medicaid/commercial deals also limits ability to capture full economics in certain markets, constraining upside.
Privia Health Group News
PRVA FAQ
What was Privia Health Group, Inc.’s price range in the past 12 months?
Privia Health Group, Inc. lowest stock price was $18.77 and its highest was $28.82 in the past 12 months.
What is Privia Health Group, Inc.’s market cap?
Privia Health Group, Inc.’s market cap is $3.39B.
When is Privia Health Group, Inc.’s upcoming earnings report date?
Privia Health Group, Inc.’s upcoming earnings report date is Aug 06, 2026 which is in 17 days.
How were Privia Health Group, Inc.’s earnings last quarter?
Privia Health Group, Inc. released its earnings results on May 07, 2026. The company reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.075 by -$0.055.
Is Privia Health Group, Inc. overvalued?
According to Wall Street analysts Privia Health Group, Inc.’s price is currently Undervalued.
Does Privia Health Group, Inc. pay dividends?
Privia Health Group, Inc. does not currently pay dividends.
What is Privia Health Group, Inc.’s EPS estimate?
Privia Health Group, Inc.’s EPS estimate is 0.07.
How many shares outstanding does Privia Health Group, Inc. have?
Privia Health Group, Inc. has 126,012,375 shares outstanding.
What happened to Privia Health Group, Inc.’s price movement after its last earnings report?
Privia Health Group, Inc. reported an EPS of $0.02 in its last earnings report, missing expectations of $0.075. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Privia Health Group, Inc.?
Currently, no hedge funds are holding shares in PRVA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Privia Health Group Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$30.60 (27.39% Upside)
$30.60 (27.39% Upside)
Blogger Sentiment
Bullish
PRVA Sentiment 70%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Increased
By 327.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $76.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.2%
Last 30 Days ▲ 11.4%
Last 30 Days ▲ 11.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
29.88%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
19.80%
Trailing 12-Months
Company Description
Privia Health Group, Inc.
Privia Health Group, Inc. functions as a national entity focused on empowering physicians throughout the United States. It partners with medical groups, health plans, and health systems, with the primary objective of optimizing physician practices, enhancing patient experiences, and appropriately compensating clinicians for care delivered both virtually and in person. To achieve this, Privia offers a comprehensive suite of services. These include technology and population health tools designed to streamline independent providers' workflows; a Management Services Organization (MSO) that alleviates administrative tasks, freeing providers to focus on clinical care; a single-TIN medical group, which bolsters payer negotiations, facilitates clinical integration, and aligns financial incentives; an Accountable Care Organization (ACO) designed to engage patients, reduce inefficient utilization, and improve care coordination and patient quality metrics, thereby advancing value-based care; and a network connecting providers with new patient populations and enabling custom contracts with purchasers and payers. Founded in 2007, the company's headquarters are located in Arlington, Virginia. Privia Health Group, Inc. was formerly a subsidiary of Brighton Health Group Holdings, LLC.
PRVA Stock 12 Month Forecast
Average Price Target
$30.60
▲(27.39% Upside)
Technical Analysis
Ownership Overview
0.88% Insiders
28.32% Mutual Funds
1.22% Other Institutional Investors
45.04% Public Companies and
Individual Investors